Literature DB >> 21337118

Practical management approaches to anticoagulation non-compliance, health literacy, and limited English proficiency in the outpatient clinic setting.

Irina Seliverstov1.   

Abstract

Warfarin is a widely used oral anticoagulant. It is highly efficacious for the treatment and prevention of thromboembolic disorders despite its narrow therapeutic window. Poor compliance with warfarin is common and a major contributor to poor anticoagulation control. A number of psychosocial issues (e.g. depressive symptoms, attitudinal and behavioral factors, cognitive function, lack of social support, limited English proficiency, health illiteracy) have been associated with warfarin non-compliance among patients in anticoagulation clinics. Patient-specific features, such as these, are important to identify in order to develop appropriate and practical interventions. Health literacy and limited English proficiency are the extension of issues related to culture, language, and ethnicity. A better understanding of patients' functioning level and health utilization factors may help to develop and target interventions for high risk patients and reduce complications from suboptimal therapy and poor warfarin management due to non-compliance. Four patient case scenarios will be used to illustrate these issues and identify potential interventions to optimize warfarin therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21337118     DOI: 10.1007/s11239-011-0560-2

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  6 in total

Review 1.  Managing oral anticoagulant therapy.

Authors:  J Ansell; J Hirsh; J Dalen; H Bussey; D Anderson; L Poller; A Jacobson; D Deykin; D Matchar
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

2.  Impact of adherence, knowledge, and quality of life on anticoagulation control.

Authors:  Nichola J Davis; Henny H Billett; Hillel W Cohen; Julia H Arnsten
Journal:  Ann Pharmacother       Date:  2005-02-15       Impact factor: 3.154

3.  Health literacy and anticoagulation-related outcomes among patients taking warfarin.

Authors:  Margaret C Fang; Edward L Machtinger; Frances Wang; Dean Schillinger
Journal:  J Gen Intern Med       Date:  2006-08       Impact factor: 5.128

4.  Can we predict daily adherence to warfarin?: Results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study.

Authors:  Alec B Platt; A Russell Localio; Colleen M Brensinger; Dean G Cruess; Jason D Christie; Robert Gross; Catherine S Parker; Maureen Price; Joshua P Metlay; Abigail Cohen; Craig W Newcomb; Brian L Strom; Mitchell S Laskin; Stephen E Kimmel
Journal:  Chest       Date:  2009-11-10       Impact factor: 9.410

5.  Patient attitudinal and behavioral factors associated with warfarin non-adherence at outpatient anticoagulation clinics.

Authors:  Dean G Cruess; A Russell Localio; Alec B Platt; Colleen M Brensinger; Jason D Christie; Robert Gross; Catherine S Parker; Maureen Price; Joshua P Metlay; Abigail Cohen; Craig W Newcomb; Brian L Strom; Stephen E Kimmel
Journal:  Int J Behav Med       Date:  2010-03

6.  Language differences as a barrier to quality and safety in health care: the Joint Commission perspective.

Authors:  Paul M Schyve
Journal:  J Gen Intern Med       Date:  2007-11       Impact factor: 5.128

  6 in total
  3 in total

1.  Anticoagulation with Warfarin: Roles of Adherence, Social Support and Illness Perception.

Authors:  Saiful Nizam M V Mohamed Koya
Journal:  Innov Pharm       Date:  2019-10-31

2.  Low socioeconomic status is associated with prolonged times to assessment and treatment, sepsis and infectious death in pediatric fever in El Salvador.

Authors:  Ronald Gavidia; Soad L Fuentes; Roberto Vasquez; Miguel Bonilla; Marie-Chantal Ethier; Caroline Diorio; Miguela Caniza; Scott C Howard; Lillian Sung
Journal:  PLoS One       Date:  2012-08-22       Impact factor: 3.240

3.  Development and validation of a measure of health literacy in the UK: the newest vital sign.

Authors:  Gill Rowlands; Nina Khazaezadeh; Eugene Oteng-Ntim; Paul Seed; Suzanne Barr; Barry D Weiss
Journal:  BMC Public Health       Date:  2013-02-07       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.